Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management

被引:79
作者
Ceravolo, Roberto [1 ]
Frosini, Daniela [1 ]
Rossi, Carlo [1 ]
Bonuccelli, Ubaldo [1 ]
机构
[1] Univ Pisa, Dept Neurosci, Pisa, Italy
关键词
Impulse control disorders; Parkinson's disease; Dopamine receptor agonists;
D O I
10.1016/S1353-8020(09)70847-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is increasing awareness that impulse control disorders (ICDs), including pathological gambling, hypersexuality, compulsive eating and buying, can occur as a complication of Parkinson's disease (PD). In addition, other impulsive or compulsive disorders have been reported to occur, including dopamine dysregulation syndrome (DDS) and punding. Case reports and prospective studies have reported an association between ICDs and the use of dopamine receptor agonists at higher doses, and DDS has been associated with L-dopa at higher doses or short-acting dopamine receptor agonists. Risk factors for ICDs include male sex, younger age or younger age at PD onset, a pre-PD history of ICD symptoms, history of substance use or bipolar disorder, and a personality profile characterized by impulsiveness. The management of clinically significant ICD symptoms should consist of modifications to dopamine replacement therapy, particularly dopamine receptor agonists, which is usually associated with an improvement of ICDs. There is no empirical evidence supporting the use of psychiatric drugs for ICDs in PD. Functional neuroimaging studies such as functional MRI and PET can investigate in vivo the neurobiological basis of these pathological behaviours. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S111 / S115
页数:5
相关论文
共 50 条
  • [31] Zonisamide in managing impulse control disorders in Parkinson's disease
    Emilio Bermejo, Pedro
    Ruiz-Huete, Cristina
    Anciones, Buenaventura
    JOURNAL OF NEUROLOGY, 2010, 257 (10) : 1682 - 1685
  • [32] Screening for impulse control disorders in Parkinson's disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors
    Contin, Manuela
    Lopane, Giovanna
    Marini, Luca
    Mohamed, Susan
    Sambati, Luisa
    De Massis, Patrizia
    Guarino, Maria
    Sermi, Simonetta
    Persichella, Chiara
    Cortelli, Pietro
    Calandra-Buonaura, Giovanna
    NEUROLOGICAL SCIENCES, 2023, 44 (02) : 565 - 572
  • [33] Screening for impulse control disorders in Parkinson’s disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors
    Manuela Contin
    Giovanna Lopane
    Luca Marini
    Susan Mohamed
    Luisa Sambati
    Patrizia De Massis
    Maria Guarino
    Simonetta Sermi
    Chiara Persichella
    Pietro Cortelli
    Giovanna Calandra-Buonaura
    Neurological Sciences, 2023, 44 : 565 - 572
  • [34] Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease
    Liu, Bo
    Luo, Wenjing
    Mo, Yingmin
    Wei, Chunying
    Tao, Ran
    Han, Min
    NEUROSCIENCE LETTERS, 2019, 707
  • [35] Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus
    Debove, Ines
    Paschen, Steffen
    Amstutz, Deborah
    Cardoso, Francisco
    Corvol, Jean-Christophe
    Fung, Victor S. C.
    Lang, Anthony E.
    Martinez Martin, Pablo
    Rodriguez-Oroz, Maria C.
    Weintraub, Daniel
    Krack, Paul
    Deuschl, Guenther
    Sarfo, Fred Stephen
    Akpalu, Albert Kwaku
    Okubadejo, Njideka
    Shalash, Ali Soliman
    Hattori, Nobutaka
    Lee, Jee-Young
    O'Sullivan, Sean
    Antonini, Angelo
    Biundo, Roberta
    Leentjens, Albert
    van den Heuvel, Odile
    Anheim, Mathieu
    Martinez-Castrillo, Juan Carlos
    Ruiz, Pedro Garcia
    Armstrong, Melissa
    Claassen, Daniel
    Rodriguez-Violante, Mayela
    Gatto, Emilia
    Evans, Andrew
    MOVEMENT DISORDERS, 2024, 39 (02) : 235 - 248
  • [36] Analysis of Impulse Control Disorders (ICDs) and Factors Associated with Their Development in a Parkinson's Disease Population
    Garcia-Rubio, Mauricio Ivan
    Otero-Cerdeira, Maria Elisa
    Toledo-Lozano, Christian Gabriel
    Alcaraz-Estrada, Sofia Lizeth
    Suarez-Cuenca, Juan Antonio
    Coral-Vazquez, Ramon Mauricio
    Mondragon-Teran, Paul
    Pineda-Juarez, Juan Antonio
    Diaz-Lopez, Luis Fernando
    Garcia, Silvia
    HEALTHCARE, 2021, 9 (10)
  • [37] Management of Impulse Control Disorders with Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
    Amstutz, Deborah
    Paschen, Steffen
    Lachenmayer, Martin Lenard
    Maradan-Gachet, Marie Elise
    Deuschl, Gunther
    Krack, Paul
    Debove, Ines
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2020, 19 (08) : 611 - 617
  • [38] Impulse Control and Related Disorders in Parkinson's Disease
    Weintraub, Daniel
    Nirenberg, Melissa J.
    NEURODEGENERATIVE DISEASES, 2013, 11 (02) : 63 - 71
  • [39] Impulse control and related disorders in Parkinson's disease
    Vargas, Antonio Pedro
    Costa Cardoso, Francisco Eduardo
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2018, 76 (06) : 399 - 410
  • [40] Impulse control and related disorders in Parkinson's disease
    Katzenshlager, R.
    NERVENHEILKUNDE, 2008, 27 (08) : 721 - 727